Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition capable of preventing and treating vitreous opacity and preparation method of pharmaceutical composition

A technology of vitreous turbidity and composition, which is applied in the field of pharmaceutical composition and its preparation for prevention and treatment of vitreous turbidity, and can solve the problem that ultrasound cannot be used for fresh lesions

Inactive Publication Date: 2017-05-31
JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Modern medicine mostly uses corticosteroid hormones, hemostasis, anticoagulation, enzyme preparations, iodine preparations, calcium preparations, ultrasound, sodium iodide iontophoresis, laser and vitrectomy, etc., but ultrasound, laser and surgery cannot be used for fresh lesions Most patients, especially those with mild symptoms, are unwilling to accept surgical treatment, so it is necessary to find new and effective treatments

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1: the pharmaceutical composition and preparation method thereof of preventing and treating vitreous opacity

[0032] The composition and parts by weight of the raw materials of the pharmaceutical composition for preventing and treating vitreous opacity are: Fujimoto Yeguanmen 308g, Leopard medicine rattan 285g, Viola japonica 12g, Yizhuxiang 163g, Zhejiang Lingzixiang 61g;

[0033] Preparation:

[0034] (1) According to the ratio of raw materials, take Fujimoto Yeguanmen, Leopard Teng, Asterolite, Yizhuxiang, Zhejiang Lingzixiang, mix them evenly, use ethanol with a concentration of 39% by weight as a solvent, and extract by warm soaking at 27°C. The number of extractions is 2 times, each extraction time is 37 hours, and the amount of solvent used each time is 75 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A recovers ethanol, and concentrates to a relative density of 1.07 , filtered, the med...

Embodiment 2

[0037] Embodiment 2: the pharmaceutical composition of preventing and treating vitreous opacity and preparation method thereof

[0038] The composition and parts by weight of the raw materials of the pharmaceutical composition for preventing and treating vitreous opacity are: Fujimoto Yeguanmen 306g, Leopard medicine rattan 288g, Asterite 10g, Yizhuxiang 164g, Zhejiang Lingzixiang 60g;

[0039] Preparation:

[0040] (1) According to the ratio of raw materials, take Fujimoto Yeguanmen, Leopard Teng, Asterolite, Yizhuxiang, Zhejiang Lingzixiang, mix them evenly, use ethanol with a concentration of 39% by weight as a solvent, and extract by warm soaking at 27°C. The number of extractions is 2 times, each extraction time is 37 hours, and the amount of solvent used each time is 75 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A recovers ethanol, and concentrates to a relative density of 1.07 , filtered, the medicinal...

Embodiment 3

[0043] Embodiment 3: the pharmaceutical composition and preparation method thereof of preventing and treating vitreous opacity

[0044] The composition and parts by weight of the raw materials of the pharmaceutical composition for preventing and treating vitreous opacity are: Fujimoto Yeguanmen 310g, Leopard medicine rattan 282g, Viola solanum 14g, Yizhuxiang 162g, Zhejiang Lingzixiang 62g;

[0045] Preparation:

[0046] (1) According to the ratio of raw materials, take Fujimoto Yeguanmen, Leopard Teng, Asterolite, Yizhuxiang, Zhejiang Lingzixiang, mix them evenly, use ethanol with a concentration of 39% by weight as a solvent, and extract by warm soaking at 27°C. The number of extractions is 2 times, each extraction time is 37 hours, and the amount of solvent used each time is 75 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A recovers ethanol, and concentrates to a relative density of 1.07 , filtered, the medi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition capable of preventing and treating vitreous opacity and a preparation method of the pharmaceutical composition. The pharmaceutical composition is prepared by taking leaf and root of Argyreia osyrensis (Roth) Choisy var.cinerea Hand.-Mazz, root of cynanchum decipiens, bark of trachelospermum axillare, common anotis herb and all-grass of chekiang chelonopsis as crude drugs and proportioning; the pharmaceutical composition can be prepared into various preparations according to a conventional preparation process and has the remarkable curative effect on prevention and treatment of the vitreous opacity.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a pharmaceutical composition for preventing and treating vitreous opacity and a preparation method thereof. Background technique [0002] Vitreous opacities (vitreous opacities) is not the name of the disease but the most common phenomenon of the vitreous. A variety of eye diseases can cause vitreous opacity, the most common ones are senile degeneration, myopic changes, posterior vitreous detachment, and physiological floaters. In addition, retinal detachment, uveitis, primary familial amyloidosis, and flashing vitreous Liquefaction and other clinical manifestations such as dark shadows in front of the eyes may also appear. The vitreous body is a transparent jelly-like tissue, clear and bright, which can stabilize the performance of the vitreous gel and ensure that the vitreous body and the surrounding retina are cushioned when the eyeball rotat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/74A61P27/02
CPCA61K36/39A61K36/24A61K36/27A61K36/53A61K36/74A61K2236/333A61K2236/39A61K2236/51A61K2236/55
Inventor 不公告发明人
Owner JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com